An unexpected role in the regulation of CD133 mRNA in breast tumor cells was reported for the beta-2 isoform of PLC (PLC-β2) (Figure 2), poorly expressed in normal breast tissues and upregulated in tumor cells, in which sustains motility of invasive cells [72, 73]. This evidence concerns the gene PLCB2 and breast neoplasm.